title: Characteristics of patients losing vision after 2 years of monthly dosing in the phase III ranibizumab clinical trials.
authors.affiliation: Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida 33136, USA. prosenfeld@med.miami.edu
authors.forename: Philip J
authors.initials: PJ
authors.lastname: Rosenfeld
authors.forename: Howard
authors.initials: H
authors.lastname: Shapiro
authors.forename: Lisa
authors.initials: L
authors.lastname: Tuomi
authors.forename: Mary
authors.initials: M
authors.lastname: Webster
authors.forename: Julee
authors.initials: J
authors.lastname: Elledge
authors.forename: Barbara
authors.initials: B
authors.lastname: Blodi